Last week in Edinburgh at the Mobile Clinical Trial Congress I gave a talk about how Mobile First Clinical Trials will transform the $100 Billion p/a Clinical Research Industry. You can view the slide deck here and watch a recording of the talk and slides in the above YouTube video.
Some links to points made and companies mentioned in the talk that you may find helpful:
Laurie Becklund: LA Times: As I lay dying and ‘Treat me like a statistic and save my life’ Medicine X Talk
The 2,000 year old model of healthcare is broken forever and the opportunity to consign this approach to history won’t make sense until we all appreciate that the product the healthcare industry makes is not office visits.
Alivecor smartphone connected ECG: My initial thoughts on this device in 2010 and after getting to trial it in the clinic back in 2011, the Alivecor passes Arthur C Clarkes 3rd law, Alivecor founder channels Steve Jobs with one more thing and a new use for that little pocket on your jeans…
Can you think of anything that I missed or should’ve mentioned?
*** UPDATE FRIDAY 10th APRIL 2015 ***
While I’m only advocating Pharma takes a ‘Mobile First’ approach (read this post by Tomi Ahonen to get a full understanding of what this means) to Clinical Trials it’s interesting that Apple’s currently the only mobile brand that I think has so far put together (with the combination of it’s 700 million devices, HealthKit, ResearchKit, app & accessory partners) an offering that will enable this.
It’s not that I think there’s something technical that no one else can do but that Apple has already engaged the Healthcare provider community, disrupted the mobile industry and as Seth Godin explains so elegantly choices are contagious:
To have any hope of making the radical change in the Clinical Trial industry that I suggest in my talk Apple’s in a very fortunate position because Hospitals, Healthcare Professionals and Patients are showing up with enthusiasm for Apple’s products and services. The success of things like Apple’s FaceTime, WiFi calling/sms, Pay, etc, might seem inconsequential to someone with deep Pharma industry expertise but they mean that Patients and Carers are arriving having made the decision to get involved because they know to some extent what to expect.
*** UPDATE FRIDAY 17th APRIL 2015 ***
There’s at least 2 interesting ResearchKit discussions taking place in the Linkedin mHealth group that are well worth checking out/joining: